New England Biotech Headlines Today is November 08, 2009. All times in Eastern Time. 11/07/2009 - 07:00 AM DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations 11/06/2009 - 01:00 PM Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council 11/06/2009 - 08:30 AM Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD) 11/06/2009 - 08:00 AM GTC Biotherapeutics Reports Third Quarter 2009 Financial Results 11/06/2009 - 07:30 AM TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post 11/06/2009 - 07:15 AM RXi Pharmaceuticals Appoints Noah D. Beerman as CEO 11/06/2009 - 07:13 AM ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society 11/05/2009 - 05:18 PM Accellent Inc. Announces Timing of Third Quarter 2009 Earnings Release and Conference Call 11/05/2009 - 04:43 PM FDA Approves Gloucester Pharmaceuticals’ ISTODAX® for Patients with Cutaneous T-cell Lymphoma 11/05/2009 - 04:05 PM Targacept Reports Third Quarter 2009 Financial Results 11/05/2009 - 04:03 PM Millipore Reports Third Quarter 2009 Financial Results 11/05/2009 - 04:00 PM Alkermes Reports Second Quarter Fiscal 2010 Financial Results 11/05/2009 - 02:47 PM Alexion to Present at Credit Suisse’s 2009 Healthcare Conference 11/05/2009 - 02:39 PM AdvanSource Biomaterials Files Patent for Silicone-Urethane Copolymers 11/05/2009 - 12:04 PM Celldex Therapeutics to Present at Merriman Curhan Ford’s Investor Summit 2009 1 2 3 4 5   Next »

About Us   |   Contact Us   |   Privacy Statement   |   Terms of Use   |   © Business Wire 2009